Cargando…

Effect of Onopordon acanthium L. as Add on Antihypertensive Therapy in Patients with Primary Hypertension Taking Losartan: a Pilot Study

Purpose: Onopordon acanthium L. is known for its medicinal properties. Our recent study showed that its seed extract is a novel natura angiotensin-converting-enzyme inhibitor (ACEI). This study was carried out to investigate its possible antihypertensive effects in patients receiving losartan. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghods, Roshanak, Gharouni, Manouchehr, Amanlou, Massoud, Sharifi, Niusha, Ghobadi, Ali, Amin, Gholamreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896397/ https://www.ncbi.nlm.nih.gov/pubmed/29670841 http://dx.doi.org/10.15171/apb.2018.009

Ejemplares similares

Effects of onopordia, a novel isolated compound from Onopordon acanthium, on pentylenetetrazole-induced seizures in mice: Possible involvement of nitric oxide pathway
por: Hassanzadeh, Malihe, et al.
Publicado: (2019)

Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay
por: Sharifi, Niusha, et al.
Publicado: (2013)

Hypertension From the Perspective of Iranian Traditional Medicine
por: Ghods, Roshanak, et al.
Publicado: (2014)

A Randomized, Triple-Blind, Placebo-Controlled, Add-On Clinical Trial to Evaluate the Efficacy of Emblica officinalis in Uncontrolled Hypertension
por: Ghaffari, Samad, et al.
Publicado: (2020)

Chemical profile and phytotoxic action of Onopordum acanthium essential oil
por: Wei, Caixia, et al.
Publicado: (2020)

Probable Etiology of Hypertension According To the Iranian Traditional Medicine
por: GHAROONI, Manoochehr, et al.
Publicado: (2014)

Results of the trycort: Cohort study of add-on antihypertensives for treatment of resistant hypertension
por: Janković, Slobodan M., et al.
Publicado: (2023)

Effects of Antihypertensive Agents on Intestinal Contractility in the Spontaneously Hypertensive Rat: Angiotensin Receptor System Downregulation by Losartan
por: Patten, Glen Stephen, et al.
Publicado: (2017)

Traditional Medicine Plant, Onopordum acanthium L. (Asteraceae): Chemical Composition and Pharmacological Research
por: Garsiya, Ekaterina Robertovna, et al.
Publicado: (2019)

The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients
por: Andrade-Sierra, Jorge, et al.
Publicado: (2022)

Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study
por: Hosoya, Tatsuo, et al.
Publicado: (2011)

Antihypertensive and antihyperglycemic effects of combinations of losartan with metformin and/or glibenclamide in desoxycorticosterone acetate and streptozotocin-induced hypertensive diabetic rats
por: Moke, Emuesiri Goodies, et al.
Publicado: (2023)

Investigation of the Antiproliferative Properties of Natural Sesquiterpenes from Artemisia asiatica and Onopordum acanthium on HL-60 Cells in Vitro
por: Molnár, Judit, et al.
Publicado: (2016)

Onopordum acanthium L. extract attenuates pancreatic β-Cells and cardiac inflammation in streptozocin-induced diabetic rats
por: Sharef, Abdalmuhaimen Yusif, et al.
Publicado: (2023)

A Novel Pulse-Taking Device for Persian Medicine Based on Convolutional Neural Networks
por: Nafisi, Vahid Reza, et al.
Publicado: (2022)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
por: Akbar Nekooeian, Ali, et al.
Publicado: (2021)

Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartan
por: Citterio, Lorena, et al.
Publicado: (2021)

Hypertensive emergency occurred due to forgetting to take antihypertensive medication: A case study
por: Bereda, Gudisa
Publicado: (2023)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
por: Gupta, Sumeet, et al.
Publicado: (2019)

Tetrahydrocurcumin Add‐On therapy to losartan in a rat model of diabetic nephropathy decreases blood pressure and markers of kidney injury
por: Khazaeli, Mahyar, et al.
Publicado: (2023)

Magnitude of Pharmacological Nonadherence in Hypertensive Patients Taking Antihypertensive Medication from a Community Pharmacy in Spain
por: Perseguer-Torregrosa, Zeneida, et al.
Publicado: (2014)

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome
por: Vitale, Cristiana, et al.
Publicado: (2005)

Health-care costs of losartan and candesartan in the primary treatment of hypertension
por: Henriksson, M, et al.
Publicado: (2011)

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
por: Park, C. G., et al.
Publicado: (2001)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Bharati, Sandesh Madhukar, et al.
Publicado: (2016)

Effect of losartan and atenolol on insulin sensitivity in nondiabetic hypertensive patients
por: Rakesh, K. B., et al.
Publicado: (2016)

The impact of an URAT1 polymorphism on the losartan treatment of hypertension and hyperuricemia
por: Wu, Liting, et al.
Publicado: (2021)

Does Losartan reduce the severity of COVID-19 in hypertensive patients?
por: Mirjalili, Mohammadreza, et al.
Publicado: (2022)

Xerostomia and Salivary Flow in Patients Taking Antihypertensive Drugs
por: Ramírez Martínez-Acitores, Lucía, et al.
Publicado: (2020)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
por: Sepehri, Zahra, et al.
Publicado: (2016)

Synthesis of Some Spiro Indeno[1,2-b]pyrido[2,3-d]Pyrimidine-5,3′-Indolines as New Urease Inhibitors
por: Mohammadi Ziarani, Ghodsi, et al.
Publicado: (2016)

Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease
por: Morrell, Nicholas W, et al.
Publicado: (2005)

Cost-effectiveness of candesartan versus losartan in the primary preventive treatment of hypertension
por: Granström, Ola, et al.
Publicado: (2012)

Losartan improves alveolar bone dynamics in normotensive rats but not in hypertensive rats
por: Mulinari-Santos, Gabriel, et al.
Publicado: (2019)

Frequency and predictors of compliance among patients taking antihypertensive medicines
por: Mutneja, Ekta, et al.
Publicado: (2020)

Tankyrase Inhibitor for Cardiac Tissue Regeneration: an In-silico Approach
por: Hosseini, Faezeh Sadat, et al.
Publicado: (2021)

Correction: Atorvastatin, Losartan and Captopril Lead to Upregulation of TGF-β, and Downregulation of IL-6 in Coronary Artery Disease and Hypertension
por: Sepehri, Zahra, et al.
Publicado: (2017)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6areje31cf5i7rg2bim5k1rme8